Related Experiment Video
Updated: Aug 28, 2026

Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance
Published on: May 2, 2018
Quinolone resistance from a transferable plasmid
L Martínez-Martínez1, A Pascual, G A Jacoby
1Department of Clinical Microbiology, School of Medicine, University of Seville, Spain.
Background:
Bacteria can mutate to acquire quinolone resistance by target alterations or diminished drug accumulation. Plasmid-mediated resistance to quinolones in clinical isolates has been claimed but not confirmed. We investigated whether a multiresistance plasmid could transfer resistance to quinolones between bacteria.
Methods:
We transferred resistance between strains by conjugation. The resistance plasmid was visualised in different hosts by agarose-gel electrophoresis. We determined the frequency of spontaneous mutations to ciprofloxacin or nalidixic-acid resistance in Escherichia coli strains, with or without the quinolone resistance plasmid.
Findings:
A multiresistance plasmid (pMG252) from a clinical isolate of Klebsiella pneumoniae was found to increase quinolone resistance to minimum inhibitory concentrations (MICs) as high as 32 microg/mL for ciprofloxacin when transferred to strains of K pneumoniae deficient in outer-membrane porins. Much lower resistance was seen when pMG252 was introduced into K pneumoniae or E coli strains with normal porins. The plasmid had a wide host range and expressed quinolone resistance in other enterobacteriaceae and in Pseudomonas aeruginosa. From a plasmid-containing E coli strain with ciprofloxacin MIC of 0.25 microg/mL and nalidixic-acid MIC of 32 microg/mL, quinolone-resistant mutants could be obtained at more than 100 times the frequency of a plasmid-free strain, reaching MICs for ciprofloxacin of 4 microg/mL and for nalidixic acid of 256 microg/mL.
Interpretation:
Transferable resistance to fluoroquinines and nalidixic acid has been found in a clinical isolate of K pneumoniae on a broad host range plasmid. Although resistance was low in wild-type strains, higher levels of quinolone resistance arose readily by mutation. Such a plasmid can speed the development and spread of resistance to these valuable antimicrobial agents.
Insights
A multiresistance plasmid from Klebsiella pneumoniae can transfer quinolone resistance between bacteria. This plasmid accelerates the development and spread of resistance to important antimicrobial agents.
Area of Science:
- Microbiology
- Genetics
- Antimicrobial Resistance
Background:
- Bacteria develop quinolone resistance through target alteration or reduced drug accumulation.
- Plasmid-mediated quinolone resistance in clinical isolates remains unconfirmed.
- This study investigates the transferability of quinolone resistance via a multiresistance plasmid.
Purpose of the Study:
- To determine if a multiresistance plasmid can transfer quinolone resistance between bacterial strains.
- To assess the impact of plasmid transfer on quinolone resistance levels.
- To investigate the role of spontaneous mutation in enhancing plasmid-mediated quinolone resistance.
Main Methods:
- Conjugation was used to transfer the resistance plasmid (pMG252) between bacterial strains.
- Agarose-gel electrophoresis visualized the plasmid in various hosts.
- Frequencies of spontaneous mutations conferring resistance to ciprofloxacin and nalidixic acid were determined in Escherichia coli strains with and without the plasmid.
Main Results:
- The pMG252 plasmid increased quinolone resistance in Klebsiella pneumoniae strains lacking outer-membrane porins (ciprofloxacin MIC up to 32 µg/mL).
- Lower resistance levels were observed in strains with normal porins, but the plasmid showed a broad host range, including E. coli, other enterobacteriaceae, and Pseudomonas aeruginosa.
- Quinolone-resistant mutants arose over 100 times more frequently in plasmid-containing E. coli, reaching higher minimum inhibitory concentrations (MICs).
Conclusions:
- Transferable quinolone and nalidixic acid resistance was confirmed in a clinical Klebsiella pneumoniae isolate on a broad-host-range plasmid.
- While plasmid-mediated resistance was low in wild-type strains, spontaneous mutations readily increased resistance levels.
- Such plasmids can significantly accelerate the emergence and dissemination of resistance to critical antimicrobial drugs.
Related Concept Videos
Antibiotic Selection
Plasmids
Conjugation
Transduction
Development of Antibiotic Resistance
Inhibitors of Bacterial DNA Synthesis

